This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Erin Gardner
Introduction
Erin Gardner is a notable inventor based in Fairfax Station, Virginia. He has made significant contributions to the field of medical science, particularly in the area of angiogenesis inhibition. His work has implications for treating neoplasms and other conditions related to unwanted blood vessel growth.
Latest Patents
Erin Gardner holds 1 patent for his invention titled "Tetrahalogenated compounds useful as inhibitors of angiogenesis." This patent outlines methods for inhibiting a neoplasm in a subject and describes the administration of a therapeutically effective amount of at least one novel tetrahalogenated compound, or a pharmaceutically acceptable salt thereof.
Career Highlights
Throughout his career, Erin has worked with various esteemed organizations. Notably, he has been associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this capacity has contributed to advancements in public health and medical research.
Collaborations
Erin has collaborated with several professionals in his field, including Michael Gutschow and Agnieszka Ambrozak. Their combined expertise has fostered innovative approaches to tackling complex medical challenges.
Conclusion
Erin Gardner's contributions to the field of angiogenesis inhibition highlight the importance of innovation in medical science. His patent and collaborations reflect a commitment to improving health outcomes through research and development.